Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer’s Sunny Outlook: Florida Medicaid Program Is Paying Off, Firm Says

Executive Summary

Pfizer believes that early results from its disease management program in Florida validate the theory that increased pharmaceutical use can help reduce state health budgets

You may also be interested in...



Pfizer “Evolves” From Rx To Health Care Company: Fla. Medicaid Is Blueprint

Pfizer plans to follow the blueprint set by its disease management agreement in Florida to forge "creative" agreements with other public and private payors, CFO David Shedlarz told the J.P. Morgan health care conference in San Francisco Jan. 14

Pfizer “Evolves” From Rx To Health Care Company: Fla. Medicaid Is Blueprint

Pfizer plans to follow the blueprint set by its disease management agreement in Florida to forge "creative" agreements with other public and private payors, CFO David Shedlarz told the J.P. Morgan health care conference in San Francisco Jan. 14

Pfizer Florida Medicaid Accounting Will Be Ready In March; Is Texas Next?

Pfizer plans to submit a first-year report on its Florida Medicaid disease management program to the state in mid-March

Related Content

UsernamePublicRestriction

Register

PS041168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel